Apache II score and prediction of ventilator-associated pneumonia (VAP)

P. Peyrani, T. Wiemken, P. Cabral, M. Gnoni, M. Luz Paz, M. Del Carmen Venero, J. Ramirez (Louisville, United States Of America)

Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Session: Assessment of severity in respiratory infections: severity scales and biomarkers
Session type: Thematic Poster Session
Number: 2373
Disease area: Respiratory critical care

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Peyrani, T. Wiemken, P. Cabral, M. Gnoni, M. Luz Paz, M. Del Carmen Venero, J. Ramirez (Louisville, United States Of America). Apache II score and prediction of ventilator-associated pneumonia (VAP). Eur Respir J 2009; 34: Suppl. 53, 2373

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Does the use of the CURB-65 score improve outcomes in community-acquired pneumonia (CAP)?
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009


Mortality in patients with ventilator-associated pneumonia (VAP) and severe sepsis is determined by the number of organ failures
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

Specific treatment failure of the ventilator-associated pneumonia (VAP): predictive values
Source: Eur Respir J 2006; 28: Suppl. 50, 786s
Year: 2006

Type of acute respiratory failure and development of ventilator-associated pneumonia (VAP)
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

Site of care for community-acquired pneumonia (CAP) patients with CRB-65 score of 0-1 and pneumonia severity index (PSI) risk class (RC) of IV-V: what to do when this discrepancy occurs. Results from the CAPO international study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Validation of pneumonia severity models for healthcare-associated pneumonia (HCAP)
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010

Ventilator-associated pneumonia (VAP): epidemiology, empirical treatment and outcome
Source: Eur Respir J 2005; 26: Suppl. 49, 188s
Year: 2005

Ventilator – associated pneumonia (VAP)
Source: Eur Respir J 2004; 24: Suppl. 48, 547s
Year: 2004

CUR-65 score for community-acquired pneumonia predicted mortality better than CURB-65 score in low-mortality-rate settings
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015


Predicting severe sepsis in community-acquired pneumonia using CURB65 and PSI scores
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008

Performance of CURB-65 and CURB-age in community acquired pneumonia (CAP)
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009


Reasons that justify hospitalization for community-acquired pneumonia (CAP) patients with CURB-65 score 0-1
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Physicians should not use the pneumonia severity index (PSI) or CRB-65 in deciding the need for hospitalization in cancer patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 41s
Year: 2007

The pneumonia severity index (PSI) do not underestimate the severity of community-acquired pneumonia (CAP) in young patients: results from the CAPO international study
Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia
Year: 2008


A new severity score for community-acquired pneumonia: PARB score
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009

Biomarkers and severity in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012


Community-acquired pneumonia in COPD patients: GOLD staging is a strong predicting factor of outcome of pneumonia
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010

Prediction of clinical severity and outcome of ventilator-associated pneumonia in a tertiary hospital using the VAP PIRO scoring system
Source: Annual Congress 2011 - Pulmonary infections and sepsis
Year: 2011



GRACE: spreading knowledge about community-acquired pneumonia
Source: ISSN=ISSN 1810-6838, ISBN=, page=305
Year: 2006

Serum procalcitonin (PCT) as a marker of the severity and prognosis of ventilator-associated pneumonia (VAP)
Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia
Year: 2007